Recommendations for the oncologic pathology report and morphologic factors associated with prognosis in endometrial carcinoma;Histopathologische basisinformation und morphologische prognosefaktoren beim endometriumkarzinom

Zentralblatt fur Gynakologie

Volumn 124, Issue 1, 2002, Pages 36-44

  Horn, L C ^a   Schmidt, D ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Carcinoma; Endometrial; Histology; Prognosis; Staging

Indexed keywords

DNA; PROTEIN P53; STEROID RECEPTOR;

ARTICLE; ASCITES FLUID CYTOLOGY; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; GENE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROGNOSIS;

ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTERECTOMY; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0036187544     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20308     Document Type: Article

References (40)

1. Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation
2. Krebs in Deutschland - Häufigkeiten und trends
3. Kurzgefasste interdisziplinäre leitlinien zur diagnostik und therapie des endometriumkarzinoms
4. Rate of proliferation as a prognostic criterion in endometrial carcinoma - An immunohistochemical analysis with the monoclonal antibody KI-S1
5. Prognosefaktoren beim endometriumkarzinom
6. Independent prognostic value of peritoneal immunocytodiagnosis in endometrial carcinoma
7. Surgical staging of endometrial cancer: Evolution and responsible challenge - A personal perspective
8. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: Implications for gynecologic suveillance
9. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984-1994
10. FIGO Annual Report on the results of treatment in gynecological cancer. Vol. 24. Carcinoma of the corpus uteri
11. National Cancer Data Base/Surveillance Epidemiology and End Results: Potential insensitive-measure bias
12. Survival of European women with gynaecological tumours during the period 1978-1989
13. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
14. Cancer statistics 2000
15. Expression of vascular endothelial growth dactors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma
16. Pathologisch-anatomische aufarbeitung und morphologische basisinformationen für das management von dysplasien und karzinomen der cervix uteri
17. Präkanzeröse läsionen des endometriums: Aspekte der molekulare pathogenese und probleme der nomenklatur
18. Leitfaden für die präparation uteriner operationspräparate
19. DNA-zytometrie gynäkologischer tumoren
20. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease
21. Prognostic significance of gross myometrial invasion with endometrial cancer
22. Molekulare pathogenese des endometriumkarzinoms auf der basis eines dualistischen modells
23. Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women with hormone replacement therapy
24. Prognostic factors, associated with recurrence in clinical stage I adenocarcinoma of the endometrium
25. Routes of lymphatic spread: A study of 112 consecutive patients with endometrial cancer
26. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1
27. PTEN a protean tumor suppressor
28. Prognostic factors in endometrial neoplasia: Old and new
29. Surgical staging of endometrial cancer: Does the patient benefit?
30. Vorschlag zur einheitlichen definierung eines immunreaktiven scores (IRS) für den immunhistochemischen östrogenrezeptornachweis (ER-ICA) im mammakarzinomgewebe
31. Präkanzerose läsionen des endometriums und veränderungen unter tamoxifen-therapie
32. Recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease
33. Protocoll for the examination of specimens from patients with carcinomas of the endometrium
34. Molecular and cytogenetic pretreatment risk assessment in endometrial carcinoma
35. Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis
36. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hematoxylin and eosin staining is compared to immunohistochemical staining
37. Villoglandular adenocarcinoma of the Endometrium: A clinicopathologic study of 61 cases